Phragmites australis — a helophytic grass — can establish successful partnership with phenol-degrading bacteria in a floating treatment wetland

Helophytic plants contribute significantly in phytoremediation of a variety of pollutants due to their physiological or biochemical mechanisms. Phenol, which is reported to have negative/deleterious effects on plant metabolism at concentrations higher than 500 mg/L, remains hard to be removed from the environmental compartments using conventional phytoremediation procedures. The present study aims to investigate the feasibility of using P. australis (a helophytic grass) in combination with three bacterial strains namely Acinetobacter lwofii ACRH76, Bacillus cereus LORH97, and Pseudomonas sp. LCRH90, in a floating treatment wetland (FTW) for the removal of phenol from contaminated water. The strains were screened based on their phenol degrading and plant growth promoting activities. We found that inoculated bacteria were able to colonize in the roots and shoots of P. australis, suggesting their potential role in the successful removal of phenol from the contaminated water. Pseudomonas sp. LCRH90 dominated the bacterial community structure followed by A. lowfii ACRH76 and B. cereus LORH97. The removal rate was significantly high when compared with the individual partners, i.e., plants and bacteria separately. The plant biomass, which was drastically reduced in the presence of phenol, recovered significantly with the inoculation of bacterial consortia. Likewise, highest reduction in chemical oxygen demand (COD), biochemical oxygen demand (BOD), and total organic carbon (TOC) is achieved when both plants and bacteria were employed. The study, therefore, suggests that P. australis in combination with efficient bacteria can be a suitable choice to FTWs for phenol-degradation in water.     

New insights into the binding mode of pyridine-3-carboxamide inhibitors of E. coli DNA gyrase

Previously we have reported on a series of pyridine-3-carboxamide inhibitors of DNA gyrase and DNA topoisomerase IV that were designed using a computational de novo design approach and which showed promising antibacterial properties. Herein we describe the synthesis of additional examples from this series aimed specifically at DNA gyrase, along with crystal structures confirming the predicted mode of binding and in vitro ADME data which describe the drug-likeness of these compounds.     

WHAT DO WE KNOW ABOUT THE HERITABILITY OF DEVELOPMENTAL INSTABILITY? ANSWERS FROM A BAYESIAN MODEL

In spite of over half a century of research, little is known about the genetic basis of developmental instability (DI). The estimation of the heritability of DI is seriously hampered by the fact that fluctuating asymmetry-FA, that is, the observable outcome of DI-only poorly reflects DI. This results in an underestimation of the heritability of DI. Current methods transforming heritabilities in FA into those of DI fail to take all sources of variation into account and yield incorrect confidence bands that are usually based on unrealistic assumptions. Therefore, a Bayesian latent variable model is developed and explored. Simulations show that with sample sizes currently applied in empirical studies, extremely wide posterior distributions are obtained and data do not allow to distinguish between high (0.5) and low (0.1) heritabilities of DI at all. Even sample sizes of 5000 result in very wide posteriors in many cases. Furthermore, for smaller samples (250 and 1250), up to 70% of the estimates of the heritability of DI were below the mean expected value because of the high skewness of its distribution. Knowing that in only one study, sample sizes were above 5000, there is a need for larger studies to evaluate the evolutionary potential of DI. Designs with relatively low numbers of sires (1-2% of total number of offspring) appear most efficient. Because such high sample sizes are hard to obtain for many study organisms, more insights are required about how data from different traits can be combined in a single analysis. In addition, new designs and methods, such as QTL analyses and micro-array techniques, should be applied to gain a better understanding of the genetic basis of DI.     

p53 suppression overwhelms DNA polymerase eta deficiency in determining the cellular UV DNA damage response

Xeroderma pigmentosum variant (XP-V) cells lack the damage-specific DNA polymerase eta and have normal excision repair but show defective DNA replication after UV irradiation. Previous studies using cells transformed with SV40 or HPV16 (E6/E7) suggested that the S-phase response to UV damage is altered in XP-V cells with non-functional p53. To investigate the role of p53 directly we targeted p53 in normal and XP-V fibroblasts using short hairpin RNA. The shRNA reduced expression of p53, and the downstream cell cycle effector p21, in control and UV irradiated cells. Cells accumulated in late S phase after UV, but after down-regulation of p53 they accumulated earlier in S. Cells in which p53 was inhibited showed ongoing genomic instability at the replication fork. Cells exhibited high levels of UV induced S-phase gammaH2Ax phosphorylation representative of exposed single strand regions of DNA and foci of Mre11/Rad50/Nbs1 representative of double strand breaks. Cells also showed increased variability of genomic copy numbers after long-term inhibition of p53. Inhibition of p53 expression dominated the DNA damage response. Comparison with earlier results indicates that in virally transformed cells cellular targets other than p53 play important roles in the UV DNA damage response.     

Epstein–Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression

Viral noncoding RNAs (Epstein–Barr virus-encoded RNAs, EBERs) are believed to play a critical role in the progression of lymphoma and nasopharyngeal carcinoma (NPC). However, the accurate mechanisms accounting for their oncogenic function have not been elucidated, especially in terms of interaction between tumor cells and mesenchymal cells. Here, we report that, in addition to NPC cells, EBERs are also found in endothelial cells in Epstein–Barr virus (EBV)-infected NPC parenchymal tissues, which implicates NPC-derived extracellular vesicles (EVs) in transmitting EBERs to endothelial cells. In support of this hypothesis, we first ascertained if EBERs could be transferred to endothelial cells via EVs isolated from NPC culture supernatant. Then, we clarified that EVs-derived EBERs could promote angiogenesis through stimulation of VCAM-1 expression. Finally, we explored the involvement of EBER recognition by TLR3 and RIG-I in NPC angiogenesis. Our observations collectively illustrate the significance and mechanism of EVs-derived EBERs in angiogenesis and underlie the interaction mechanisms between EBV-infected NPC cells and the tumor microenvironment.     

Retracted: Advanced glycation end-products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEs under diabetic conditions

Despite the administration of exogenous insulin and other medications used to control many aspects of diabetes mellitus (DM), increased oxidative stress has been increasingly acknowledged in DM development and complications. Therefore, this study aims to investigate the role of advanced glycation end-products (AGEs) in oxidative stress (OS) of thyroid cells in patients with DM. Patients with DM with or without thyroid dysfunction (TD) were enrolled. Thyroid toxic damage was induced by adding AGE-modified bovine serum albumin (AGE-BSA) to normal human thyroid follicular epithelial cells. The cell viability, cell cycle, and cell apoptosis, as well as the content of reactive oxygen species (ROS), catalase (CAT), and malondialdehyde (MDA) in cells were measured. Thyroid hormones, T3, T4, FT3, and FT4 levels were measured by enzyme-linked immunosorbent assay. Receptor for advanced glycation end products (RAGE), sirtuin1 ( Sirt1), and NF-E2-related factor 2 ( Nrf2) expressions were detected, and the mitochondrial membrane potential was measured. We found increased AGEs in the serum of DM patients with TD. By increasing AGE-BSA concentration, cell viability; the thyroid hormones T3, T4, FT3, and FT4 levels; and mitochondrial membrane potential all significantly decreased. However, the increase in AGE-BSA concentration led to an increase in cell apoptosis, RAGE, and nuclear factor-κB expressions but produced the opposite effect on Sirt1, Nrf2, and heme oxygenase-1 expressions, as well as a decrease in antioxidant response element protein levels. The AGE-BSA increased ROS and MDA levels and reduced CAT level in normal human thyroid follicular epithelial cells on a dose independence basis. Our results demonstrated that AGEs-mediated direct increase of RAGE produced OS in thyroid cells of DM by inactivating the Sirt1/Nrf2 axis.     

Considerations about the chirality of the saturated six-membered rings with two or more heteroatoms

The chirality of the title heterocycles is discussed considering their genesis by desymmetrization of the corresponding adamantanes. Some rules for the specification of the absolute configurations of the enantiomers (R or S) for this type of compounds are proposed. © 1996 Wiley-Liss, Inc.     

In situ pH maintenance for mammalian cell cultures in shake flasks and tissue culture flasks

pH in animal cell cultures decreases due to production of metabolites like lactate. pH control via measurement and base addition is not easily possible in small‐scale culture formats like tissue‐culture flasks and shake flasks. A hydrogel‐based system is reported for in situ pH maintenance without pH measurement in such formats, and is demonstrated to maintain pH between 6.8 and 7.2 for a suspension CHO cell line in CD CHO medium and between 7.3 and 7.5 for adherent A549 cells in DMEM:F12 containing 10% FBS. This system for pH maintenance, along with our previous report of hydrogels for controlled nutrient delivery in shake flasks can allow shake flasks to better mimic bioreactor‐based fed batch operation for initial screening during cell line and process development for recombinant protein production in mammalian cells. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012